Oric Pharmaceuticals, Inc. ORIC Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$35.77M-19.1% | -$30.51M+16.0% | -$32.59M+5.7% | -$36.36M-13.7% | -$30.02M-20.0% | ||
| $270K-10.6% | $320K+5.3% | $288K+6.7% | $310K+14.0% | $302K+15.7% | ||
| $6.9M+5.2% | $6.28M+20.7% | $5.63M+11.4% | $6.57M+31.6% | $6.55M+32.2% | ||
| -$3.32M+58.0% | -$448K-115% | —— | -$248K— | -$7.91M-37.4% | ||
| $679K+18.1% | -$2.11M-56.0% | -$782K+52.1% | $532K+22.6% | $575K-76.1% | ||
| -$32.44M+0.3% | -$22.48M+19.9% | -$25.11M+12.8% | -$30.84M-20.4% | -$32.53M-7.8% | ||
| $2K-99.5% | $227K+3.7% | $35K-91.6% | $63K-81.1% | $387K+77.5% | ||
| $77.97M+20.6% | $45.29M+30.8% | $165.5M+206% | $124.37M+154% | $64.66M-43.5% | ||
| -$17.98M-180% | —— | -$110.54M— | -$76.93M— | $22.45M+136% | ||
| $60.88M— | $0— | $110.44M— | $133.93M— | $0-100% | ||
| $61.14M+555,718% | $1.5M+161% | $109.45M+86,766% | $134.3M+16,359% | $11K-100.0% | ||
| $10.73M+207% | -$4M-126% | -$26.2M— | $26.53M— | -$10.07M-131% | ||
| -$162K-118% | $240K-85.3% | $587K-69.8% | $591K-74.3% | $882K-60.4% | ||
| $270K-10.6% | $320K+5.3% | $288K+6.7% | $310K+14.0% | $302K+15.7% | ||
| $679K+18.1% | -$2.11M-56.0% | -$782K+52.1% | $532K+22.6% | $575K-76.1% | ||
| —— | —— | —— | —— | -$242K— | ||
| $993K— | $0— | $1.74M— | $656K— | $0-100% | ||
| -$32.44M+1.5% | -$22.71M+19.7% | -$25.15M+13.9% | -$30.91M-19.1% | -$32.92M-8.3% | ||
| -$32.44M+1.5% | -$22.71M+19.7% | -$25.15M+13.9% | -$30.91M-19.1% | -$32.92M-8.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Oric Pharmaceuticals, Inc. generate?
- Oric Pharmaceuticals, Inc. (ORIC) generated -$110.9M in operating cash flow over the trailing twelve months.
- What is Oric Pharmaceuticals, Inc.'s free cash flow?
- After $327.0K of capital expenditures, Oric Pharmaceuticals, Inc.'s free cash flow was -$111.2M over the trailing twelve months, up 4.4% year over year.
- Where does Oric Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Oric Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.